You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

regional gastrointestinal carcinoid tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting
  • Carcinoid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 14, 2022

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Tumors, Tumor Metastasis, Metastatic Gastrointestinal Carcinoid Tumor Trial in China, United States (EMB-01)

Recruiting
  • Neoplasms
  • +2 more
  • Canton, Ohio
  • +3 more
Apr 12, 2022

Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

Recruiting
  • Carcinoid Syndrome
  • +3 more
  • Dual-Energy Computed Tomography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2021

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)

Completed
Has Results
  • Carcinoid Syndrome
  • Los Angeles, California
  • +53 more
Sep 15, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

Completed
Has Results
  • Gastrin-Producing Neuroendocrine Tumor
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 25, 2020

Colorectal Cancer, Colo-rectal Cancer, ctDNA Trial in Randers (ctDNA-analysis, Intensified Follow-up Schedule)

Recruiting
  • Colorectal Cancer
  • +14 more
  • ctDNA-analysis
  • Intensified Follow-up Schedule
  • Randers, Denmark
    Surgical Department, Randers Regional Hospital
Jun 20, 2022

HER2-positive Breast Cancer, HER2 Low, SYD-985 Trial in Aurora (Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

Recruiting
  • HER2-positive Breast Cancer
  • +26 more
  • Vic-trastuzumab duocarmazine (SYD985) + paclitaxel
  • Aurora, Colorado
    University of Colorado Cancer Center
Oct 22, 2021

Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib

Recruiting
  • Atypical Carcinoid Tumor
  • +18 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +425 more
Aug 12, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)

Completed
  • Carcinoid Tumor
  • Acromegaly
  • Los Angeles, California
  • +16 more
Dec 17, 2020

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Carcinoid Syndrome Trial in Worldwide (BIM 23A760)

Terminated
Has Results
  • Carcinoid Syndrome
  • BIM 23A760
  • Vienna, Austria
  • +53 more
Nov 4, 2020

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in San Francisco, Vallejo (bevacizumab, 5-fluorouracil,

Terminated
Has Results
  • Gastrointestinal Carcinoid Tumor
  • +4 more
  • bevacizumab
  • +3 more
  • San Francisco, California
  • +1 more
Dec 12, 2019

CNS Cancer, Head Neck Cancer, GI Cancer Trial in New York (Pencil Beam Scanning Proton Therapy)

Recruiting
  • CNS Cancer
  • +6 more
  • Pencil Beam Scanning Proton Therapy
  • New York, New York
    The New York Proton Center
Mar 29, 2022

Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

Recruiting
  • Locally Advanced Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Neoplasm
  • Placebo Administration
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2023

Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best

Completed
Has Results
  • Advanced NET of GI Origin
  • +2 more
  • La Jolla, California
  • +96 more
Jul 13, 2021

Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

Completed
Has Results
  • Carcinoid Tumor of the Small Bowel
  • Neuroendocrine Tumour
  • Los Angeles, California
  • +38 more
Mar 10, 2022

Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • +2 more
  • Stereotactic Ablative Radiation Therapy
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Nov 20, 2023

Cognitive Function Trial in Nantong (acetaminophen mannitol, Normal saline)

Recruiting
  • Cognitive Function
  • acetaminophen mannitol
  • Normal saline
  • Nantong, Jiangsu, China
    Affiliated Hospital of nantong University
Aug 20, 2023

Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

Recruiting
  • Neuroendocrine Tumor
  • Beijing, Chao Yang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023